Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease
阿尔茨海默病中的酰基链重塑和区域脂质失调
基本信息
- 批准号:10624511
- 负责人:
- 金额:$ 41.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:ATP binding cassette transporter 1Acyl Coenzyme AAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAmyloid beta-ProteinAmyloid beta-Protein PrecursorAnimal ModelAnimalsApolipoprotein EAtlasesAutopsyBehavioralBiological MarkersBiologyBrainBrain regionCerebrospinal FluidCoenzyme A LigasesCognitiveCognitive deficitsDataData SetDiseaseDocosahexaenoic AcidsElectrophysiology (science)Electrospray IonizationEmerging TechnologiesEnzymesEtiologyExplosionGenesGeneticGenetic studyGenotypeHeadHippocampus (Brain)HomeostasisHumanHuman GeneticsInositolInvestigationKnock-inKnock-outKnowledgeLate Onset Alzheimer DiseaseLeadLearningLipidsLiquid substanceLong-Term PotentiationMapsMass Spectrum AnalysisMediator of activation proteinMemoryMetabolicMetabolic PathwayMethodsMusNatureNerve DegenerationNeurodegenerative DisordersPathologicPathologyPathway interactionsPerformancePhenocopyPhosphatidylinositolsPhospholipase A2PhospholipidsPhosphoric Monoester HydrolasesPhysiologicalPlasmaPolyphosphatesPolyunsaturated Fatty AcidsPredispositionReportingResistanceRodentSYNJ1 geneSupport SystemSynapsesSystemTestingTg2576TherapeuticTransgenesVariantWild Type MouseWorkabeta accumulationage relatedaging brainbasebiomarker discoverybrain cellbrain tissuecell typecholesterol transporterscognitive functionembryonic stem cellexhaustionfamilial Alzheimer diseasegenetic manipulationgenetic risk factorgenetic variantgenome wide association studyhigh riskhuman datahuman diseaselipid metabolismlipid transportlipidomelipidomicsliquid chromatography mass spectrometrymass spectrometric imagingmetabolomicsmouse geneticsmouse modeloverexpressionphospholipase D2spatial memorysynthetic enzymetherapeutic targetwater maze
项目摘要
Accumulating data from human and mouse support the hypothesis that system level lipid disregulation is an
early and critical factor in etiology and progression of Alzheimer's disease (AD). The explosion of 'omics
methods in the past decade has resulted in a proliferation of various studies and data sets that interrogate
specific regions of the brain. Using Imaging Mass Spectrometry (IMS), our preliminary studies have found
regionally differential lipid composition in coronal sections from wild type mouse brain and a mouse model of
Alzheimer's disease over expressing the amyloid precursor protein (APP) transgene. This regional lipid
disregulation requires system-wide interrogation of lipid homeostasis which can singularly be accomplished
with lididomics. A candidate based screen of lipid modifying enzymes in mouse embryonic stem cells for
resistance to Aβ-triggered synapse loss, identified multiple metabolic enzymes which may be responsible for
exit of polyunsaturated fatty acids (PUFA), specifically docosahexaenoic acid (DHA) from an acyl chain
remodeling pathway, the Land's cycle. The Land's cycle has recently been identified to be dysfunctional in two
animal models of AD. In the human context, DHA transport into the brain is aberrant by age 30, in carriers of a
variant of apolipoprotein E (ApoE4) strongly associated with AD risk. Synthesis of these results with multiple
hits from GWAS implicating lipid metabolism and transport, strongly support system-wide dyshomeostatis of
acyl chain composition in the brain. However, the reports of regionally defined lipid composition are currently
limited. We propose to test the hypothesis that acyl chain composition among multiple lipid classes is severely
disregulated in brain regions known to be susceptible in AD including hippocampus and entorhynal cortex.
Using IMS we will interrogate the lipid composition of mouse models of AD, Tg2576 and targeted replacement
APOE mice as well as human brain tissue. We will then test the hypothesis that DHA accretion is a critical
modifier of AD associated behavioral deficits and pathology in mouse models using knock-out lines of acyl-
CoA synthetase 6 (Acsl6), a key mediator of DHA enrichment in the brain. We will generate new strains of
Tg2576 and TRAPOE4 lacking Acsl6 and overexpressing Acsl6 to determine both necessity and sufficiency of
DHA brain accretion for AD associated deficits. Finally, we will integrate and assemble our data into a
publically available lipid brain atlas. These studies have potential to synthesize accumulating lipidomics data in
aging and neurodegenerative disease. The use of spatial lipidomics at scale in the brain has not been yet be
comprehensively accomplished, and is required for clear understanding of the basic metabolic pathways thus
uncovering connectivity and functionality in the brain. Completion of these studies will represent compelling
evidence for the critical nature of lipid composition in basic biology of AD and lead to new strategies for
biomarker discovery as well as therapeutic targets.
来自人类和小鼠的数据积累数据支持了系统水平脂质不处调的假设是一种
阿尔茨海默氏病(AD)病因学和进展的早期和关键因素。 'omics的爆炸
过去十年中的方法导致了各种研究和数据集的扩散
大脑的特定区域。使用成像质谱法(IMS),我们的初步研究发现
野生型小鼠脑的冠状切片和小鼠模型的区域差异脂质组成
阿尔茨海默氏病在表达淀粉样蛋白前体蛋白(APP)转化而疾病。这种区域脂质
不脱离需要对脂质稳态的全系统询问,这可以单一完成
与lididomics。基于候选的脂质修饰酶在小鼠胚胎干细胞中的酶
对Aβ触发的突触损失的抗性,确定了多种代谢酶
多不饱和脂肪酸(PUFA)的出口,特别是酰基链中的二十二烯酸(DHA)
改建路径,土地的周期。该土地的周期最近被确定为功能失调
AD的动物模型。在人类的背景下,DHA在30岁时进入大脑的异常
载脂蛋白E(APOE4)的变体与AD风险密切相关。这些结果与多个结果合成
GWAS隐式脂质代谢和运输的命中,强烈支持全系统范围内的dyshomeostatis
大脑中的酰基链组成。但是,当前有区域定义的脂质成分的报告
有限的。我们建议检验以下假设:多种脂质类别之间的酰基链组成严重
在已知在包括海马和内纳尔皮质在内的广告中易感的大脑区域中没有调节。
使用IMS,我们将询问AD,TG2576的鼠标模型的脂质组成和靶向替换
APOE小鼠以及人脑组织。然后,我们将检验以下假设,即DHA积聚是关键
AD相关行为的修饰符使用酰基的敲除线定义了小鼠模型中的病理学
COA合成酶6(ACSL6),大脑中DHA富集的关键介体。我们将产生新的菌株
TG2576和TRAPOE4缺少ACCSL6和过表达ACSL6,以确定必要和充分性
DHA脑积聚相关的缺陷。最后,我们将集成并将我们的数据集成到一个
公开可用的脂质脑图集。这些研究有可能合成在
衰老和神经退行性疾病。在大脑中大规模使用空间脂质组学的使用尚未
全面完成,是对基本代谢途径的清晰理解所必需的
揭示大脑中的连通性和功能。这些研究的完成将代表令人信服的
脂质组成在AD基本生物学中的批判性质的证据,并导致新的策略
生物标志物发现以及治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura Beth Johnson McIntire其他文献
Laura Beth Johnson McIntire的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura Beth Johnson McIntire', 18)}}的其他基金
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain
阿尔茨海默病人和小鼠大脑中脂质组的空间失调
- 批准号:
10705302 - 财政年份:2022
- 资助金额:
$ 41.57万 - 项目类别:
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain
阿尔茨海默病人和小鼠大脑中脂质组的空间失调
- 批准号:
10516567 - 财政年份:2022
- 资助金额:
$ 41.57万 - 项目类别:
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease
阿尔茨海默病中的酰基链重塑和区域脂质失调
- 批准号:
10685399 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease
阿尔茨海默病中的酰基链重塑和区域脂质失调
- 批准号:
10317926 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
Acyl chain remodeling and regional lipid dysregulation in Alzheimer's disease
阿尔茨海默病中的酰基链重塑和区域脂质失调
- 批准号:
10358810 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
Contribution of BIN1 and Synj1 to endosomal pathogenesis Alzheimer's Disease and Down Syndrome
BIN1 和 Synj1 对阿尔茨海默病和唐氏综合症内体发病机制的贡献
- 批准号:
9904807 - 财政年份:2019
- 资助金额:
$ 41.57万 - 项目类别:
The role of a novel atypical monoamine transporter in Alzheimer's disease
新型非典型单胺转运蛋白在阿尔茨海默病中的作用
- 批准号:
8917841 - 财政年份:2014
- 资助金额:
$ 41.57万 - 项目类别:
The role of a novel atypical monoamine transporter in Alzheimer's disease
新型非典型单胺转运蛋白在阿尔茨海默病中的作用
- 批准号:
9278064 - 财政年份:2014
- 资助金额:
$ 41.57万 - 项目类别:
Screening lipid modifying enzymes to ameliorate A-beta triggered synaptic loss
筛选脂质修饰酶以改善 A-β 引发的突触损失
- 批准号:
8874327 - 财政年份:2014
- 资助金额:
$ 41.57万 - 项目类别:
Screening lipid modifying enzymes to ameliorate A-beta triggered synaptic loss
筛选脂质修饰酶以改善 A-β 引发的突触损失
- 批准号:
8770745 - 财政年份:2014
- 资助金额:
$ 41.57万 - 项目类别:
相似国自然基金
水稻酰基辅酶A氧化酶基因OsACX2调控花粉高温耐性分子机制研究
- 批准号:32301765
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
酰基辅酶A合成酶ACS-2对线虫帕金森疾病模型的调控研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
酰基辅酶A合成酶ACS-2对线虫帕金森疾病模型的调控研究
- 批准号:32200486
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
酰基辅酶A氧化酶3(ACOX3)遗传变异与二叶式主动脉瓣发生风险关联及功能研究
- 批准号:82103925
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核黄素调节多种酰基辅酶A脱氢缺陷症ETF-QO突变蛋白稳定性的机制研究
- 批准号:82101471
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity
饮食诱导肥胖中 ALCAT1 激活 NLRP3 的细胞机制
- 批准号:
10658507 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Studies on the impact of acetyl-cysteine on metabolism
乙酰半胱氨酸对代谢影响的研究
- 批准号:
10574934 - 财政年份:2022
- 资助金额:
$ 41.57万 - 项目类别:
Peroxisomal fatty acid metabolism in genetic and age-related disorders
遗传和年龄相关疾病中的过氧化物酶体脂肪酸代谢
- 批准号:
10559614 - 财政年份:2022
- 资助金额:
$ 41.57万 - 项目类别:
Peroxisomal fatty acid metabolism in genetic and age-related disorders
遗传和年龄相关疾病中的过氧化物酶体脂肪酸代谢
- 批准号:
10371815 - 财政年份:2022
- 资助金额:
$ 41.57万 - 项目类别: